Instituto de Salud Global de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2022

  1. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

    Gates Open Research, Vol. 6

  2. Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control

    The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347

2020

  1. Teladorsagia circumcincta beta tubulin: the presence of the E198L polymorphism on its own is associated with benzimidazole resistance

    Parasites & vectors, Vol. 13, Núm. 1, pp. 453

  2. Zoonotic implications of onchocerca species on human health

    Pathogens, Vol. 9, Núm. 9, pp. 1-17